Parkinson’s disease and chronic inflammatory demyelinating polyneuropathy with celiac disease: Improvement in neuropathy but not Parkinson’s symptoms after intravenous immunoglobulin and gluten free diet
Objective: To report a case of celiac disease in Parkinson's disease and CIPD, and examine the relationship. Background: Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) is a…Identification and Documentation of Delirium in Parkinson’s Disease
Objective: To establish documentation, assessment and diagnosis practices in the medical notes of inpatients with Parkinson’s disease (PD) and delirium. Background: Delirium is a neuropsychiatric…Association between BDNF Val66Met polymorphism and mild behavioral impairment in patients with Parkinson’s patients
Objective: This study investigates if PD patients with Brain-derived-neurotrophic-factor (BNDF) Met allele are more likely to have Mild behavioral impairment (MBI). And whether Met allele…The Personalized Parkinson Project – data quality enhancing strategies
Objective: Demonstrate the impact of quality enhancing strategies in the Personalized Parkinson Project. Background: Increasingly, the scientific community uses data from longitudinal observational patient cohorts…AADC gene therapy administered via a posterior approach: 18-month results from the PD-1102 trial in advanced Parkinson’s disease
Objective: To report 18-month safety and clinical outcomes from a phase 1, open-label trial of VY-AADC01 (NBIb-1817) for Parkinson’s disease (PD) patients with motor fluctuations.…Comparison of Categorical- and Verbatim-Reported Postural Instability Symptoms Among Fox Insight Parkinson Research Participants
Objective: To analyze verbatim patient-reported problems compared with ordinal measures referable to Postural Instability (PI) symptoms in the Fox Insight (FI) observational study. Background: FI…Cardiovascular Fitness, Plasma Biomarkers and Dopaminergic Denervation in Parkinson’s Disease
Objective: To examine the relationship between cardiovascular (CV) fitness, plasma biomarkers associated with PD progression and/or exercise and dopaminergic denervation, measured by I-123-Ioflupane single photon…A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of AKST4290 in Subjects with Parkinson’s Disease on Stable Dopaminergic Treatment (TEAL Study)
Objective: Assessment of efficacy and safety in subjects with Parkinson’s disease (PD) following treatment for 12 weeks with placebo or AKST4290, a highly specific and…Helicobacter pylori eradication in Parkinson’s disease: A double-blind randomized placebo-controlled study
Objective: To evaluate the effects of Helicobacter pylori eradication on PD symptoms. Background: Globally, H. pylori infection remains a common problem. Cross-sectional studies in Parkinson's disease (PD)…Opicapone study in daily clinical practice. OPRA study
Objective: Improvement of off time and increase of ON time without dyskinesias at 6 months compared to the baseline situation. Secondary Endpoints: Determine the rate…
- « Previous Page
- 1
- …
- 17
- 18
- 19
- 20
- 21
- …
- 149
- Next Page »